SPOKANE, Wash., Oct. 21, 2025 /PRNewswire/ — Today, KOSPET officially launches the TANK T4 and TANK M4, rugged GPS smartwatches bringing pro-level durability, dive-ready water resistance, dual-band navigation with offline maps, with full training and wellness suite to a new price tier: $209.99. Designed for athletes and explorers who are born to win, T4 and M4 deliver premium capabilities enthusiasts expect, without premium-brand markup.
KOSPET recently announced Olympic Champion, Cole Hocker, as its newest brand ambassador. This partnership reflects the brand’s performance ethos and athlete-driven product direction.
Built to challenge the “$600–$2,000” adventure class
Premium adventure watches from established brands promote advanced features at the $599–$1,999 price points. KOSPET’s competitive T4/M4 enter ultra-rugged training and navigation at a fraction of the cost, at $209.99, focusing on the features athletes use every day.
What you get with KOSPET T4 and M4:
“We strategically engineered T4 and M4 to deliver the core pro features, including a rugged build, dual-band GPS with offline maps, serious training and dive metrics, without forcing athletes to spend four to ten times the amount,” says Martin Wu, CEO of KOSPET.
Where KOSPET leads: At a Glance
Product Details
Pricing & Availability
KOSPET TANK T4 and TANK M4 are now available online and at global retailers for $209.99 USD / €209.99 / £209.99. Find KOSPET online at https://kospet.com/.
About KOSPET
Founded in 2018, KOSPET has become a global leader in smart wearables, setting the gold standard for sports, outdoor adventures, and lifestyle smartwatches. With a global community of over 8 million users, KOSPET’s innovative smartwatches combine rugged durability with advanced technology offering AMOLED displays, dual-band GNSS positioning, extended battery life, and professional training features powered by the proprietary Apexmove OS.
Media Contact:
Ronjini Joshua
(949) 295-9779
403288@email4pr.com
SOURCE KOSPET
WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…
KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…